– Sirius Medical announces a large funding round to further accelerate sales growth and new product development
Sirius Pintuition®: moving from localization to navigation with surgical markers
EINDHOVEN, The Netherlands, March 28, 2023 /PRNewswire/ — Sirius Medical, a leader in surgical marker navigation, today announced the successful closing of a €12 million Series B Round. The funding will accelerate the worldwide growth of its Pintuition product and support further product development. Holland Capital acted as lead investor for this Series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium and significant investment from Sirius Medical management and team. Norgine Ventures joined as a new investor in this round to support further business rollout.
Sirius’ state-of-the-art navigation system, Pintuition, provides surgeons with real-time distance and directional navigation guidance to locate tumors with ease and precision. With more than 100 active centers and more than 5,000 successful Pintuition procedures in Western Europe and the United States, the company experienced unprecedented revenue growth in 2022, attributable to Pintuition’s ease of use, straightforward implementation, and unmatched precision. to locate the target tissue.
“Sirius Medical has done a great job developing and bringing Pintuition technology to market with a strong commercial start,” said Peter Stein, CEO of Norgine Ventures. “Norgine Ventures is pleased to support Sirius Medical’s leadership and vision to deliver cost-effective solutions in surgery.”
“We are excited about the market potential of surgical marker navigation,” said Jan Frens van Giessel, partner at Holland Capital. “We believe the Pintuition technology and its future innovations will significantly improve non-palpable tumor surgery for patients, clinicians, and improve care for cancer patients.”
“To have become the fastest growing company in the industry is clear confirmation of the unique benefits our technology brings to both patients and physicians,” said Bram Schermers, CEO of Sirius Medical. “With the backing of this latest round of funding, I am confident that our highly talented and motivated team will further drive Pintuition adoption around the world.”
About Sirius Medical With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving the care of cancer patients by delivering unsurpassed yet affordable solutions that enable the precise and efficient removal of tumors. Pintuition technology is precise, simple, affordable, and is CE marked and FDA approved. Sirius Medical is expanding rapidly with more than 100 locations and an international sales network in Europe and the United States.
www.sirius-medical.com | @SiriusMedical |
Contact: benjamin.tchang@sirius-medical.com
Photo – https://mma.prnewswire.com/media/2041093…
View original content: https://www.prnewswire.com/news-releases/sirius-medical-anuncia-una-gran-ronda-de-financiacion-301783105.html
